scorecardresearch
Friday, March 29, 2024
Support Our Journalism
HomeScienceHCQ doesn’t help clear coronavirus, a small study in China finds

HCQ doesn’t help clear coronavirus, a small study in China finds

HCQ didn’t help patients clear virus better than standard care & was much more likely to cause side effects, according to study of 150 patients in China.

Follow Us :
Text Size:

Paris: Hydroxychloroquine, the 65-year-old malaria drug that President Donald Trump has praised, appeared not to help patients get rid of the pathogen in a small study.

The pill didn’t help patients clear the virus better than standard care and was much more likely to cause side effects, according to a study of 150 hospitalized patients by doctors at 16 centers in China. The research, which hasn’t been peer-reviewed, was released Tuesday.

The drug did help alleviate some clinical symptoms of Covid-19, however, and the patients who took it showed a greater drop in C-reactive protein, a measure of inflammation.

“When testing new treatments, we are looking for signals that show that they might be effective before proceeding to larger studies,” said Allen Cheng, an infectious diseases physician and a professor of epidemiology at Melbourne’s Monash University. “This study doesn’t show any signal, so it is probably unlikely that it will be of clinical benefit.”

There were more side effects in the group of 75 people who took hydroxychloroquine, but they were mostly mild, the most common being diarrhea. The researchers, led by Wei Tang of Ruijin Hospital in Shanghai, wrote that the medicine’s anti-inflammatory effects probably helped alleviate patients’ symptoms.

More studies of hydroxychloroquine are underway after the medicine made headlines in recent weeks and was endorsed by Trump.

“The results of those studies will be of interest,” Cheng said. -Bloomberg


Also read: Modi govt is monitoring daily production of HCQ, drug inspectors posted at Zydus, Ipca sites


 

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

3 COMMENTS

  1. So what… Studies in China can’t be trusted… N please stop praising china… If china would want it could control the infection…

  2. This story contains a very obvious contradiction, one that any Trump supporter would point out to invalidate the conclusion.

    From the article:
    ——————–
    The drug did help alleviate some clinical symptoms of Covid-19, however, and the patients who took it showed a greater drop in C-reactive protein, a measure of inflammation.

    “When testing new treatments, we are looking for signals that show that they might be effective before proceeding to larger studies,” said Allen Cheng, an infectious diseases physician and a professor of epidemiology at Melbourne’s Monash University. “This study doesn’t show any signal, so it is probably unlikely that it will be of clinical benefit.”
    ————————

    These two paragraphs contradict each other. A reduction in C-reactive protein, for a patient on a ventilator, could easily be the difference between surviving and recovering from the virus and death.

    Therefore this study *did* show a signal of clinical benefit. And this “professor of epidemiology at Melbourne’s Monash University.” should be fired for being too stupid to do his job.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular